Crossmark

Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment

Crossref DOI link: https://doi.org/10.1038/s41598-025-85776-8

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yassin, Mohamed G.

Roshdy, Aya

Marie, Aya A.
Funding

Funding for this research was provided by:

The Science, Technology & Innovation Funding Authority
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 10 June 2024

Accepted: 6 January 2025

First Online: 17 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below